title: Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response survey.
abstract: OBJECTIVE
  To investigate a broad definition of migraine resolution that extends beyond specific migraine-associated diagnostic symptoms as measured by the Completeness of Response Survey.
  
  
  METHODS
  Conducted at 8 sites, 135 subjects treated migraines with SumaRT/Nap over 2 months. To measure subjects' experiences with SumaRT/Nap compared to their usual migraine medication, the Headache Impact Test, Revised Patient Perception of Migraine Questionnaire, and Completeness of Response Survey were administered at baseline and at 2 months.
  
  
  RESULTS
  The effects of the study medicine compared to the subjects' usual migraine medicine reached statistical significance in decreasing headache severity, lessening of associated symptoms, and attaining complete relief with a single dose (60.04% of attacks resolved at 2 hours post-treatment).
  
  
  CONCLUSIONS
  Compared to a subject's usual treatment, SumaRT/Nap used early and consistently for treatment of acute migraine offers important clinical improvements, including lessening of associated symptoms beyond International Headache Society criteria.
  
  
  BACKGROUND
  NCT00893737.
authors: Headache Care Center, Springfield, MO, USA. rcady@banyangroupinc.com
authors: Roger
authors: R
authors: Cady
authors: Jim
authors: J
authors: Banks
authors: Robert B
authors: RB
authors: Nett
authors: Jerome
authors: J
authors: Goldstein
authors: Nathan
authors: N
authors: Bennett
authors: Ira M
authors: IM
authors: Turner
authors: Gary E
authors: GE
authors: Ruoff
authors: Stephen H
authors: SH
authors: Landy
authors: Kathleen
authors: K
authors: Farmer
authors: Márta
authors: M
authors: Juhász
authors: Jeanne
authors: J
authors: Tarrasch
authors: M Chris
authors: MC
authors: Runken